Cargando…

Suppressing growth and invasion of human hepatocellular carcinoma cells by celecoxib through inhibition of cyclooxygenase-2

Purpose: Biomarkers are lacking in hepatocellular carcinoma (HCC). Cyclooxygenase-2 (COX-2) and its metabolites play crucial roles in the process of inflammation-tumor transformation. This study was aimed to detect COX-2 expression in HCC tissues and evaluate the effects of a COX-2 inhibitor, celeco...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tai, Yang, Zhang, Lin-Hao, Gao, Jin-Hang, Zhao, Chong, Tong, Huan, Ye, Cheng, Huang, Zhi-Yin, Liu, Rui, Tang, Cheng-Wei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6497485/ https://www.ncbi.nlm.nih.gov/pubmed/31114336 http://dx.doi.org/10.2147/CMAR.S183376

Ejemplares similares

Suppressing Growth and Invasion of Human Hepatocellular Carcinoma Cells by Celecoxib Through Inhibition of Cyclooxygenase-2 [Corrigendum]
Publicado: (2021)

Celecoxib: a selective cyclooxygenase-2 inhibitor
por: Gandelman, M
Publicado: (2003)

Adjuvant celecoxib and lanreotide following transarterial chemoembolisation for unresectable hepatocellular carcinoma: a randomized pilot study
por: Tong, Huan, et al.
Publicado: (2017)

Effects of a selective cyclooxygenase-2 inhibitor (celecoxib) on fracture healing in rats
por: Li, Kang-Hua, et al.
Publicado: (2013)

Celecoxib attenuates hepatocyte apoptosis by inhibiting endoplasmic reticulum stress in thioacetamide-induced cirrhotic rats
por: Su, Wei, et al.
Publicado: (2020)

Celecoxib and octreotide synergistically ameliorate portal hypertension via inhibition of angiogenesis in cirrhotic rats
por: Gao, Jin-Hang, et al.
Publicado: (2016)

Correction: Celecoxib and octreotide synergistically ameliorate portal hypertension via inhibition of angiogenesis in cirrhotic rats
por: Gao, Jin-Hang, et al.
Publicado: (2022)

Inhibition of cyclooxygenase‐2 enhanced intestinal epithelial homeostasis via suppressing β‐catenin signalling pathway in experimental liver fibrosis
por: Zhang, Linhao, et al.
Publicado: (2021)

[(123)I]-Celecoxib Analogues as SPECT Tracers of Cyclooxygenase-2 in Inflammation
por: Uddin, Md. Jashim, et al.
Publicado: (2010)

Octreotide and celecoxib synergistically encapsulate VX2 hepatic allografts following transcatheter arterial embolisation
por: TONG, HUAN, et al.
Publicado: (2013)

Celecoxib reduces hepatic vascular resistance in portal hypertension by amelioration of endothelial oxidative stress
por: Tai, Yang, et al.
Publicado: (2021)

Antitumor activity of the selective cyclooxygenase-2 inhibitor, celecoxib, on breast cancer in Vitro and in Vivo
por: Dai, Zhi-Jun, et al.
Publicado: (2012)

Celecoxib impairs primary human myoblast proliferation and differentiation independent of cyclooxygenase 2 inhibition
por: Matheny, Ronald W., et al.
Publicado: (2022)

Antitumor enhancement of celecoxib, a selective Cyclooxygenase-2 inhibitor, in a Lewis lung carcinoma expressing Cyclooxygenase-2
por: Park, Won, et al.
Publicado: (2008)

Direct non-cyclooxygenase-2 targets of celecoxib and their potential relevance for cancer therapy
por: Schönthal, A H
Publicado: (2007)

The Effect of Celecoxib, a Cyclooxygenase-2 Inhibitor on Noise- Induced Hearing Loss
por: Pourbakht, Akram
Publicado: (2013)

Celecoxib Ameliorates Portal Hypertension of the Cirrhotic Rats through the Dual Inhibitory Effects on the Intrahepatic Fibrosis and Angiogenesis
por: Gao, Jin-Hang, et al.
Publicado: (2013)

Cyclooxygenase-2 inhibitor celecoxib attenuates joint contracture following immobilization in rat knees
por: Ozawa, Junya, et al.
Publicado: (2016)

Novel combination of celecoxib and metformin improves the antitumor effect by inhibiting the growth of Hepatocellular Carcinoma
por: Hu, Jun-Wen, et al.
Publicado: (2020)

Expression of cyclooxygenase-2 is correlated with lncRNA-COX-2 in cirrhotic mice induced by carbon tetrachloride
por: Tang, Shi-Hang, et al.
Publicado: (2017)

Celecoxib suppresses hepatoma stemness and progression by up-regulating PTEN
por: Chu, Tian-Huei, et al.
Publicado: (2013)

Metronomic Celecoxib Therapy in Clinically Available Dosage Ablates Hepatocellular Carcinoma via Suppressing Cell Invasion, Growth, and Stemness in Pre-Clinical Models
por: Yeh, Chun-Chieh, et al.
Publicado: (2020)

Suppression of Occurrence and Advancement of β‐Catenin‐accumulated Crypts, Possible Premalignant Lesions of Colon Cancer, by Selective Cyclooxygenase‐2 Inhibitor, Celecoxib
por: Yamada, Yasuhiro, et al.
Publicado: (2001)

Celecoxib Inhibits Hepatocellular Carcinoma Cell Growth and Migration by Targeting PNO1
por: Dai, Huijun, et al.
Publicado: (2019)

Downregulation of survivin expression and concomitant induction of apoptosis by celecoxib and its non-cyclooxygenase-2-inhibitory analog, dimethyl-celecoxib (DMC), in tumor cells in vitro and in vivo
por: Pyrko, Peter, et al.
Publicado: (2006)

Design and Synthesis of a Novel NIR Celecoxib-Based Fluorescent Probe for Cyclooxygenase-2 Targeted Bioimaging in Tumor Cells
por: Wang, Xinli, et al.
Publicado: (2020)

Antitumor and anti-metastatic effects of cyclooxygenase-2 inhibition by celecoxib on human colorectal carcinoma xenografts in nude mouse rectum
por: NINOMIYA, ITASU, et al.
Publicado: (2012)

Metformin suppresses breast cancer growth via inhibition of cyclooxygenase-2
por: Shi, Bin, et al.
Publicado: (2021)

Targeting inhibition of extracellular signal-regulated kinase kinase pathway with AZD6244 (ARRY-142886) suppresses growth and angiogenesis of gastric cancer
por: Gao, Jin-Hang, et al.
Publicado: (2015)

Telomerase reverse transcriptase inhibition stimulates cyclooxygenase 2 expression in cancer cells and synergizes with celecoxib to exert anti-cancer effects
por: Liu, T, et al.
Publicado: (2013)

Cyclooxygenase-2 promotes tumor growth and suppresses tumor immunity
por: Liu, Bing, et al.
Publicado: (2015)

Author Correction: Targeting inhibition of extracellular signal-regulated kinase kinase pathway with AZD6244 (ARRY-142886) suppresses growth and angiogenesis of gastric cancer
por: Gao, Jin-Hang, et al.
Publicado: (2022)

Cyclooxygenase-2 up-regulates hepatic somatostatin receptor 2 expression
por: Lu, Yao-Yao, et al.
Publicado: (2018)

Celecoxib inhibits insulin-like growth factor 1 induced growth and invasion in non-small cell lung cancer
por: LIU, CHEN-HUI, et al.
Publicado: (2013)

Knockdown of cyclooxygenase-2 leads to growth inhibition and cell cycle arrest in hepatocellular carcinoma cells
por: Lv, Xiuhe, et al.
Publicado: (2019)

Ardisia crispa roots inhibit cyclooxygenase and suppress angiogenesis
por: Awang Hamsin, Dayang Erna Zulaikha, et al.
Publicado: (2014)

Celecoxib alleviates zinc deficiency-promoted colon tumorigenesis through suppressing inflammation
por: Yin, Xiaolong, et al.
Publicado: (2021)

Celecoxib and 2,5‐dimethylcelecoxib inhibit intestinal cancer growth by suppressing the Wnt/β‐catenin signaling pathway
por: Egashira, Issei, et al.
Publicado: (2016)

Low-dose cyclooxygenase-2 (COX-2) inhibitor celecoxib plays a protective role in the rat model of neonatal necrotizing enterocolitis
por: Sun, Ling
Publicado: (2021)

Cytokinesis-block micronucleus assay of celecoxib and celecoxib derivatives
por: Reimann, Hauke, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_jng4ljqg8vtkgamtn8kjt1269s